Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.47 -0.14 (-0.55%) Market Cap: 40.55 Bil Enterprise Value: 65.84 Bil PE Ratio: 23.04 PB Ratio: 0.96 GF Score: 82/100

Q3 2022 Takeda Pharmaceutical Co Ltd Earnings Call Transcript

Feb 03, 2022 / 11:00AM GMT
Release Date Price: €25.55 (-1.43%)
Christopher David O;Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance

' -

[Interpreted] Thank you very much for joining our Fiscal Year 2021 Third Quarter Earnings Announcement. I am the moderator. I'm Chris O'Reilly, Head of the Global IR. And we have the interpretation button at the bottom of the Zoom. And if you'd like to listen to Japanese, please select the Japanese language. And if you like to listen to English, please select the English channel. And if you'd like to listen to the original audio, please turn the interpretation function off.

Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of the presentation material for today.

Today, our presenters as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot